A study at the University of Tennessee Health Science Center aims to develop a new way to treat ischemic stroke, a leading cause of death in adults worldwide.
The study is funded by a $1,155,000 translational grant from the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health. Jianxiong Jiang, PhD, associate professor in the Department of Pharmaceutical Sciences and the Department of Anatomy and Neurobiology, and Jiawang Liu, PhD, director of the Medicinal Chemistry core at UTHSC, are the principal investigators. Thaddeus S. Nowak, PhD, professor in the Department of Neurology, provides expertise in stroke models for the project.